Veerhealth Care — Initiating Coverage (BUY)
USFDA-approved small-cap pivoting from domestic contract manufacturing to global exports. Target price INR 120, ~140% upside.
Read the reportInsights
Deep-dive equity research, investment notes, and long-term ideas — grounded in fundamentals, not speculation.
USFDA-approved small-cap pivoting from domestic contract manufacturing to global exports. Target price INR 120, ~140% upside.
Read the reportDisclaimer: All content published here is for educational purposes only and does not constitute investment advice. SEBI Registration does not guarantee performance. Please read all related documents carefully before investing.